{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:43:35Z","timestamp":1785447815086,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["1173417"],"award-info":[{"award-number":["1173417"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01731-2","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:58:22Z","timestamp":1781963902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identifying druggable proteins of the association of chronotype on breast cancer using Mendelian randomization"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3368-9935","authenticated-orcid":false,"given":"Shan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8126-2852","authenticated-orcid":false,"given":"Yujie","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-6839","authenticated-orcid":false,"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6275-1147","authenticated-orcid":false,"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-2413","authenticated-orcid":false,"given":"Satoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6136-1836","authenticated-orcid":false,"given":"Shiu Lun","family":"Au Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"1731_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"Cancer J. Clin."},{"key":"1731_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0743-z","volume":"18","author":"V Blakeman","year":"2016","unstructured":"Blakeman, V., Williams, J. L., Meng, Q.-J. & Streuli, C. H. Circadian clocks and breast cancer. Breast Cancer Res. 18, 89 (2016).","journal-title":"Breast Cancer Res."},{"key":"1731_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16890-6","volume":"11","author":"E Hadadi","year":"2020","unstructured":"Hadadi, E. et al. Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice. Nat. Commun. 11, 3193 (2020).","journal-title":"Nat. Commun."},{"key":"1731_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2022.100428","volume":"21","author":"AJ Lawther","year":"2022","unstructured":"Lawther, A. J. et al. Disrupting circadian rhythms promotes cancer-induced inflammation in mice. Brain Behav. Immun. Health 21, 100428 (2022).","journal-title":"Brain Behav. Immun. Health"},{"key":"1731_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10654-023-00983-9","volume":"38","author":"E Schernhammer","year":"2023","unstructured":"Schernhammer, E. et al. The association between night shift work and breast cancer risk in the Finnish twins cohort. Eur. J. Epidemiol. 38, 533\u2013543 (2023).","journal-title":"Eur. J. Epidemiol."},{"key":"1731_CR6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1007\/s11427-022-2315-5","volume":"66","author":"S Tian","year":"2023","unstructured":"Tian, S. et al. Causal relationships between chronotype and risk of multiple cancers by using longitudinal data and Mendelian randomization analysis. Sci. China Life Sci. 66, 2433\u20132436 (2023).","journal-title":"Sci. China Life Sci."},{"key":"1731_CR7","doi-asserted-by":"publisher","first-page":"e1009887","DOI":"10.1371\/journal.pgen.1009887","volume":"18","author":"BL Hayes","year":"2022","unstructured":"Hayes, B. L. et al. Do sex hormones confound or mediate the effect of chronotype on breast and prostate cancer? A Mendelian randomization study. PLoS Genet. 18, e1009887 (2022).","journal-title":"PLoS Genet."},{"key":"1731_CR8","doi-asserted-by":"publisher","first-page":"l2327","DOI":"10.1136\/bmj.l2327","volume":"365","author":"RC Richmond","year":"2019","unstructured":"Richmond, R. C. et al. Investigating causal relations between sleep traits and risk of breast cancer in women: Mendelian randomisation study. BMJ 365, l2327 (2019).","journal-title":"BMJ"},{"key":"1731_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ijc.34026","volume":"151","author":"F Chen","year":"2022","unstructured":"Chen, F. et al. Mendelian randomization analyses of 23 known and suspected risk factors and biomarkers for breast cancer overall and by molecular subtypes. Int. J. Cancer 151, 372\u2013380 (2022).","journal-title":"Int. J. Cancer"},{"key":"1731_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S2213-8587(24)00132-3","volume":"12","author":"The Lancet Diabetes E","year":"2024","unstructured":"The Lancet Diabetes E Sleep: a neglected public health issue. Lancet Diab. Endocrinol. 12, 365 (2024).","journal-title":"Lancet Diab. Endocrinol."},{"key":"1731_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre, K., McCarthy, M. I. & Schwenk, J. M. Genetics meets proteomics: perspectives for large population-based studies. Nat. Rev. Genet. 22, 19\u201337 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"1731_CR12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s12276-021-00679-8","volume":"53","author":"JM Lee","year":"2021","unstructured":"Lee, J. M., Kim, H. & Baek, S. H. Unraveling the physiological roles of retinoic acid receptor-related orphan receptor \u03b1. Exp. Mol. Med. 53, 1278\u20131286 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1731_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab226","volume":"45","author":"G Baldanzi","year":"2022","unstructured":"Baldanzi, G. et al. Evening chronotype is associated with elevated biomarkers of cardiometabolic risk in the EpiHealth cohort: a cross-sectional study. Sleep 45, zsab226 (2022).","journal-title":"Sleep"},{"key":"1731_CR14","doi-asserted-by":"publisher","DOI":"10.1017\/pcm.2023.5","volume":"1","author":"I Daghlas","year":"2023","unstructured":"Daghlas, I. & Gill, D. Mendelian randomization as a tool to inform drug development using human genetics. Camb. Prism Precis. Med. 1, e16 (2023).","journal-title":"Camb. Prism Precis. Med."},{"key":"1731_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s42255-023-00742-w","volume":"5","author":"S Yoshiji","year":"2023","unstructured":"Yoshiji, S. et al. Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity. Nat. Metab. 5, 248\u2013264 (2023).","journal-title":"Nat. Metab."},{"key":"1731_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41588-024-02052-7","volume":"57","author":"S Yoshiji","year":"2025","unstructured":"Yoshiji, S. et al. Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease. Nat. Genet. 57, 345\u2013357 (2025).","journal-title":"Nat. Genet."},{"key":"1731_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s42255-023-00743-9","volume":"5","author":"SL Au Yeung","year":"2023","unstructured":"Au Yeung, S. L., Luo, S. & Kwok, K. O. Actionable targets to reduce COVID-19 severity. Nat. Metab. 5, 195\u2013196 (2023).","journal-title":"Nat. Metab."},{"key":"1731_CR18","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326, 1614\u20131621 (2021).","journal-title":"JAMA"},{"key":"1731_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08259-7","volume":"10","author":"SE Jones","year":"2019","unstructured":"Jones, S. E. et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat. Commun. 10, 343 (2019).","journal-title":"Nat. Commun."},{"key":"1731_CR20","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712\u20131721 (2021).","journal-title":"Nat. Genet."},{"key":"1731_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).","journal-title":"Science"},{"key":"1731_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"1731_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92\u201394 (2017).","journal-title":"Nature"},{"key":"1731_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","volume":"52","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat. Genet. 52, 572\u2013581 (2020).","journal-title":"Nat. Genet."},{"key":"1731_CR25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"1731_CR26","doi-asserted-by":"crossref","unstructured":"Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Primers 2, 6 (2022).","DOI":"10.1038\/s43586-021-00092-5"},{"key":"1731_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"1731_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/gepi.22506","volume":"47","author":"A Gkatzionis","year":"2023","unstructured":"Gkatzionis, A., Burgess, S. & Newcombe, P. J. Statistical methods for cis-Mendelian randomization with two-sample summary-level data. Genet. Epidemiol. 47, 3\u201325 (2023).","journal-title":"Genet. Epidemiol."},{"key":"1731_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ajhg.2022.12.017","volume":"110","author":"S Burgess","year":"2023","unstructured":"Burgess, S. et al. Using genetic association data to guide drug discovery and development: Review of methods and applications. Am. J. Hum. Genet. 110, 195\u2013214 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"1731_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber, V. et al. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am. J. Hum. Genet. 109, 767\u2013782 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"1731_CR31","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. SharePro: an accurate and efficient genetic colocalization method accounting for multiple causal signals. Bioinformatics 40, btae295 (2024).","DOI":"10.1093\/bioinformatics\/btae295"},{"key":"1731_CR32","doi-asserted-by":"publisher","first-page":"e1008720","DOI":"10.1371\/journal.pgen.1008720","volume":"16","author":"C Wallace","year":"2020","unstructured":"Wallace, C. Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses. PLoS Genet. 16, e1008720 (2020).","journal-title":"PLoS Genet."},{"key":"1731_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3758\/s13428-011-0076-x","volume":"43","author":"D Tofighi","year":"2011","unstructured":"Tofighi, D. & MacKinnon, D. P. RMediation: an R package for mediation analysis confidence intervals. Behav. Res. Methods 43, 692\u2013700 (2011).","journal-title":"Behav. Res. Methods"},{"key":"1731_CR34","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"1731_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn, G. H. et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622, 348\u2013358 (2023).","journal-title":"Nature"},{"key":"1731_CR36","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","volume":"31","author":"MJ Machiela","year":"2015","unstructured":"Machiela, M. J. & Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555\u20133557 (2015).","journal-title":"Bioinformatics"},{"key":"1731_CR37","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gkae1071","volume":"53","author":"SC Dyer","year":"2025","unstructured":"Dyer, S. C. et al. Ensembl 2025. Nucleic Acids Res. 53, D948\u2013D957 (2025).","journal-title":"Nucleic Acids Res."},{"key":"1731_CR38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi, J. S. Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet. 18, 164\u2013179 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"1731_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112021","volume":"135","author":"H Li","year":"2025","unstructured":"Li, H., Liu, M., Yin, S., Zhang, Z. & Yang, K. The biological clock gene PER2 promotes PANoptosis in oral squamous cell carcinoma by facilitating the formation of the Caspase-8\/RIPK3\/ASC complex. Cell Signal 135, 112021 (2025).","journal-title":"Cell Signal"},{"key":"1731_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43485-8","volume":"14","author":"A Malarstig","year":"2023","unstructured":"Malarstig, A. et al. Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nat. Commun. 14, 7680 (2023).","journal-title":"Nat. Commun."},{"key":"1731_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02193-0","volume":"20","author":"E Bouras","year":"2022","unstructured":"Bouras, E. et al. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 20, 3 (2022).","journal-title":"BMC Med."},{"key":"1731_CR42","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.18632\/oncotarget.13740","volume":"8","author":"J Qin","year":"2017","unstructured":"Qin, J. et al. Apoptosis-linked gene 2 promotes breast cancer growth and metastasis by regulating the cytoskeleton. Oncotarget 8, 2745\u20132757 (2017).","journal-title":"Oncotarget"},{"key":"1731_CR43","doi-asserted-by":"crossref","unstructured":"Zhu Y. G. & Li Q. C. Multifaceted roles of PDCD6 both within and outside the cell. J. Cell Physiol. 239, e31235 (2024).","DOI":"10.1002\/jcp.31235"},{"key":"1731_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1593\/neo.05682","volume":"8","author":"R Kuefer","year":"2006","unstructured":"Kuefer, R. et al. ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease. Neoplasia 8, 319\u2013329 (2006).","journal-title":"Neoplasia"},{"key":"1731_CR45","doi-asserted-by":"crossref","unstructured":"Navasatli S. A., Vahdati S. N., Arjmand T. F., Far M. M. & Behboudi H. New insight into the role of the ADAM protease family in breast carcinoma progression. Heliyon 10, e24805 (2024).","DOI":"10.1016\/j.heliyon.2024.e24805"},{"key":"1731_CR46","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1038\/s41388-021-02059-y","volume":"40","author":"EJ Ter Steege","year":"2021","unstructured":"Ter Steege, E. J. & Bakker, E. R. M. The role of R-spondin proteins in cancer biology. Oncogene 40, 6469\u20136478 (2021).","journal-title":"Oncogene"},{"key":"1731_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1832348","volume":"9","author":"L Incorvaia","year":"2020","unstructured":"Incorvaia, L. et al. Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions. Oncoimmunology 9, 1832348 (2020).","journal-title":"Oncoimmunology"},{"key":"1731_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109359","volume":"36","author":"CE Cano","year":"2021","unstructured":"Cano, C. E. et al. BTN2A1, an immune checkpoint targeting Vgamma9Vdelta2 T cell cytotoxicity against malignant cells. Cell Rep. 36, 109359 (2021).","journal-title":"Cell Rep."},{"key":"1731_CR49","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41586-023-06525-3","volume":"621","author":"L Yuan","year":"2023","unstructured":"Yuan, L. et al. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vgamma9Vdelta2 T cells. Nature 621, 840\u2013848 (2023).","journal-title":"Nature"},{"key":"1731_CR50","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch, M. et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575, 683\u2013687 (2019).","journal-title":"Nature"},{"key":"1731_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molcel.2017.01.022","volume":"65","author":"CM Henry","year":"2017","unstructured":"Henry, C. M. & Martin, S. J. Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory \u201cFADDosome\u201d complex upon TRAIL stimulation. Mol. Cell 65, 715\u201329.e5 (2017).","journal-title":"Mol. Cell"},{"key":"1731_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s43556-026-00403-w","volume":"7","author":"J Liu","year":"2026","unstructured":"Liu, J. et al. TGF-beta in tumor development and progression: mechanisms and therapeutics. Mol. Biomed. 7, 9 (2026).","journal-title":"Mol. Biomed."},{"key":"1731_CR53","doi-asserted-by":"crossref","unstructured":"Candia, J. et al. Variability of 7K and 11K SomaScan plasma proteomics assays. J. Proteome Res. 23, 5531\u20135539 (2024).","DOI":"10.1021\/acs.jproteome.4c00667"},{"key":"1731_CR54","doi-asserted-by":"publisher","first-page":"20150110","DOI":"10.1098\/rstb.2015.0110","volume":"371","author":"JA Mong","year":"2016","unstructured":"Mong, J. A. & Cusmano, D. M. Sex differences in sleep: impact of biological sex and sex steroids. Philos. Trans. R. Soc. Lond. B Biol. Sci. 371, 20150110 (2016).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"1731_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59034-4","volume":"16","author":"M Koprulu","year":"2025","unstructured":"Koprulu, M. et al. Sex differences in the genetic regulation of the human plasma proteome. Nat. Commun. 16, 4001 (2025).","journal-title":"Nat. Commun."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01731-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:04:53Z","timestamp":1782367493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01731-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01731-2","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EYFW has received research grants from the Health Bureau, the Hong Kong Research Grants Council, Narcotics Division, Security Bureau, Social Welfare Department, Labour and Welfare Bureau of the Government of the Hong Kong SAR and National Natural Science Foundation of China; serves on member of Core Team for Expert Group on Drug Registration of Pharmacy and Poisons Board. These are outside the submitted work. SLAY has received honoraria from for Standard BioTools for scientific presentations on proteomics that was unrelated to this study. The remaining authors declare no conflicts of interests. SLAY is an Editorial Board Member for\n                      Communications Medicine\n                      but was not involved in the editorial review or peer review, nor in the decision to publish this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}